{{Rsnum
|rsid=11209002
|Gene=C1orf141
|Chromosome=1
|position=67124778
|Orientation=plus
|GMAF=0.2195
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=C1orf141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 64.6 | 29.2 | 6.2
| HCB | 81.8 | 16.8 | 1.5
| JPT | 85.8 | 14.2 | 0.0
| YRI | 34.7 | 49.7 | 15.6
| ASW | 35.1 | 57.9 | 7.0
| CHB | 81.8 | 16.8 | 1.5
| CHD | 80.6 | 18.5 | 0.9
| GIH | 87.1 | 12.9 | 0.0
| LWK | 43.6 | 51.8 | 4.5
| MEX | 86.0 | 12.3 | 1.8
| MKK | 51.3 | 37.2 | 11.5
| TSI | 67.6 | 26.5 | 5.9
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs11209002
|PubMedID=17804789
|Condition=Crohn's disease
|Gene=IL23R
|Risk Allele=
|pValue=2.00E-007
|OR=2.56
|95CI=1.75-3.70
|OA=1
}}

{{PharmGKB
|RSID=rs11209002
|Name_s=
|Gene_s=C1orf141
|Feature=
|Evidence=PubMed ID:17804789; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci (Initial Sample Size: 382 trios; Replication Sample Size: 521 trios, 750 cases, 828 controls). This variant is associated with Crohn's disease. This variant is associated with Crohn's disease.
|Drugs=
|Drug Classes=
|Diseases=Crohn Disease
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356487
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11209002
|overall_frequency_n=93
|overall_frequency_d=128
|overall_frequency=0.726562
|n_genomes=46
|n_genomes_annotated=0
|n_haplomes=75
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}